Warburg Pincus to acquire a minority stake in Sebia.

Warburg Pincus, a private equity firm, agreed to acquire a minority stake in Sebia, a provider of clinical protein electrophoresis equipment and reagents. Financial terms were not disclosed. “Our mission is to provide powerful tools that translate what is happening in a patient’s body into a readable and interpretable language. We welcome Warburg Pincus as a new partner alongside our existing investor base. Their global healthcare expertise and growth orientation will help accelerate Sebia’s strategy while maintaining our commitment to scientific rigor, product quality and patient impact, helping us deliver for our customers and partners,” Jean-Marc Chermette, Sebia CEO.